EnteroMedics, A Saint Paul Minnesota-headquartered company is a developer of medical devices using nueroblocking technology to treat obesity, metabolic disease and other GI disorders. On Tuesday December 13th, the Australian Therapeutic Goods Administration approved EnteroMedics Maestro System.
The Maestro System is a first-in-class,
sustainable weight loss treatment which is designed to control both
hunger and fullness by blocking the primary nerve which regulates the
digestive systemhttp://www.rttnews.com/1780483/enteromedics-receives-australia-approval-for-the-components-of-maestro-system.aspx?type=bn
No comments:
Post a Comment